These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37908895)

  • 1. Influenza vaccination in Western Australian children: Exploring the health benefits and cost savings of increased vaccine coverage in children.
    Blyth CC; Fathima P; Pavlos R; Jacoby P; Pavy O; Geelhoed E; Richmond PC; Effler PV; Moore HC
    Vaccine X; 2023 Dec; 15():100399. PubMed ID: 37908895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
    Molnar D; Anastassopoulou A; Poulsen Nautrup B; Schmidt-Ott R; Eichner M; Schwehm M; Dos Santos G; Ultsch B; Bekkat-Berkani R; von Krempelhuber A; Van Vlaenderen I; Van Bellinghen LA
    Hum Vaccin Immunother; 2022 Nov; 18(5):2058304. PubMed ID: 35486410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old.
    Raj SM; Chughtai AA; Sharma A; Tan TC; MacIntyre CR
    Vaccine; 2019 Sep; 37(40):5979-5985. PubMed ID: 31473001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.
    Andersohn F; Bornemann R; Damm O; Frank M; Mittendorf T; Theidel U
    GMS Health Technol Assess; 2014; 10():Doc03. PubMed ID: 25371764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a routine varicella vaccination program for US children.
    Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
    JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential cost savings attributable to influenza vaccination of school-aged children.
    White T; Lavoie S; Nettleman MD
    Pediatrics; 1999 Jun; 103(6):e73. PubMed ID: 10353970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018.
    Blyth CC; Cheng AC; Crawford NW; Clark JE; Buttery JP; Marshall HS; Francis JR; McRae J; Kotsimbos T; Kelly PM; Macartney KK;
    Vaccine; 2020 Mar; 38(13):2779-2787. PubMed ID: 32107062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public health impact and return on investment of Belgium's pediatric immunization program.
    Carrico J; Mellott CE; Talbird SE; Bento-Abreu A; Merckx B; Vandenhaute J; Benchabane D; Dauby N; Ethgen O; Lepage P; Luyten J; Raes M; Simoens S; Van Ranst M; Eiden A; Nyaku MK; Bencina G
    Front Public Health; 2023; 11():1032385. PubMed ID: 37427250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.
    Damm O; Eichner M; Rose MA; Knuf M; Wutzler P; Liese JG; Krüger H; Greiner W
    Eur J Health Econ; 2015 Jun; 16(5):471-88. PubMed ID: 24859492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of the routine childhood immunization program in the United States, 2009.
    Zhou F; Shefer A; Wenger J; Messonnier M; Wang LY; Lopez A; Moore M; Murphy TV; Cortese M; Rodewald L
    Pediatrics; 2014 Apr; 133(4):577-85. PubMed ID: 24590750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.
    Reyes JF; Wood JG; Beutels P; Macartney K; McIntyre P; Menzies R; Mealing N; Newall AT
    Vaccine; 2017 Jan; 35(2):345-352. PubMed ID: 27916411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
    Butler JR; McIntyre P; MacIntyre CR; Gilmour R; Howarth AL; Sander B
    Vaccine; 2004 Mar; 22(9-10):1138-49. PubMed ID: 15003641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-specific benefit of seasonal influenza vaccine on respiratory syncytial virus-hospitalisations in children: An instrumental variable approach using population-based data.
    Le H; de Klerk N; Blyth CC; Gidding H; Fathima P; Moore HC
    Vaccine; 2023 Jul; 41(34):5029-5036. PubMed ID: 37407408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong.
    de Haas TDJ; Yeung KHT; Hutubessy R; van der Putten IM; Nelson EAS
    Vaccine; 2021 Nov; 39(46):6762-6780. PubMed ID: 34743828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of live-attenuated influenza vaccination among school-age children.
    Wenzel NS; Atkins KE; van Leeuwen E; Halloran ME; Baguelin M
    Vaccine; 2021 Jan; 39(2):447-456. PubMed ID: 33280855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.